MRTX News and Press, Mirati Therapeutics Inc. From 01/28/20

Researchers at BMO Financial Group have initiated coverage of four companies in the biotech space, with one gaining an “outperform” rating. In an email to clients sent on Tuesday (January 28), the bank confirmed that its research analyst George Farmer will now cover BioMarin Ph...

Acadia Healthcare (NASDAQ: ACHC ) resumed with Equal Weight rating and $36 (11% upside) price target at Stephens. More news on: Acadia Healthcare Company, Inc., BioMarin Pharmaceutical Inc., Blueprint Medicines Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

Mirati Therapeutics (NASDAQ: MRTX ) has priced its public offering of 3,076,924 common shares at $97.50 per share, for expected gross proceeds of ~$300M. More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Read more ...

Gainers: CHS   +26.9% . DBVT   +21.6% . AGTC   +13.9% . NNVC   +10.3% . OTCQX:AKOM   +9.1% . More news on: Chico's FAS, Inc., DBV Technologies S.A., Applied Genetic Technologies Corporation, Stocks on the move, , News on ETFs Read more ...

Biotech Pulse The biotech group closed 2019 with its longest rally of the year. It was a welcome change from what had mostly been an uphill battle. While the broader market was sailing from one high to another, biotechs and pharmaceuticals (biopharma) were still marking their 2019 lows in ea...

Mirati Therapeutics (NASDAQ: MRTX ) announces the following executive appointments: More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Read more ...

SAN DIEGO , Jan. 6, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced changes to their executive management team, effective immediately. Mirati continues to accelerate the development of the KRAS and sitravatinib pro...

Quick Take Black Diamond Therapeutics ( BDTX ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The company is developing a platform that identifies small molecule kinase inhibitors, which help to slow or stop cancer. BDTX is a ...